Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05066178 · ClinicalTrials.gov registry record · NA
Speech Treatment for Minimally Verbal Children With ASD and CAS
A NA study of Autism Spectrum Disorder and Developmental Verbal Dyspraxia, sponsored by MGH Institute of Health Professions.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05066178 is a NA study of Autism Spectrum Disorder and Developmental Verbal Dyspraxia that is actively recruiting participants, run by MGH Institute of Health Professions. The registered enrollment target is 20 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05066178, a NA study of Autism Spectrum Disorder and Developmental Verbal Dyspraxia, is actively recruiting participants, sponsored by MGH Institute of Health Professions.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.
Conditions Studied
Interventions
- BEHAVIORAL CAS Treatment for Minimally Verbal Children with Autism
Study Locations (1)
Massachusetts
- MGH Institute of Health Professions - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05066178
The ClinicalTrials.gov registry entry for NCT05066178 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (85% lower). The listed sponsor is MGH Institute of Health Professions, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which CAS Treatment for Minimally Verbal Children with Autism is the first listed.
NCT05066178 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05066178 about?
NCT05066178 is a clinical study titled "Speech Treatment for Minimally Verbal Children With ASD and CAS". Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with ...
What is the current status of trial NCT05066178?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-05-01. Estimated completion is 2026-11-30.
What conditions does trial NCT05066178 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Developmental Verbal Dyspraxia.
What interventions are being tested in trial NCT05066178?
The interventions under investigation include: CAS Treatment for Minimally Verbal Children with Autism (BEHAVIORAL).
Who is sponsoring clinical trial NCT05066178?
This trial is sponsored by MGH Institute of Health Professions, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05066178 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Explore more on PlainTrial
Autism Spectrum Disorder
All registered trials for this condition
Developmental Verbal Dyspraxia
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.